After a median follow-up of 15 months, 135 of the 514 patients treated with pembrolizumab and 216 of the 505 patients treated with placebo

A study of a community sample of 389 non-Hispanic Caucasian young adult women aged 18 to 30 years, who had tanned indoors at least once in t